Latest Retinoids Stories
Basel, Switzerland, July 31, 2008 - Basilea Pharmaceutica Ltd.
LAUSANNE, Switzerland, July 16 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor and Welfare has approved Differin(R) Gel 0.1% (adapalene), a novel topical treatment for acne vulgaris in Japan.
The newest skin creams beckon with an air of scientific gravitas, holding out the hope that now, at last, medicine has triumphed over the visible aging process.
As prom season looms, here's some advice from Dr. Jason Green, a dermatologist, on treating and preventing acne. 1Hormones, stress: "No one's too old to have acne," Green says.
By Hunter, Simon JOURNALS WATCH Too busy to catch
TEANECK, N.J., Oct. 25 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., today announces the completion of Eisai's acquisition of four oncology-related products from Ligand Pharmaceuticals.
WASHINGTON (Reuters) - A well-known acne drug may increase cholesterol and other fat levels more than previously thought, U.S. researchers said on Monday.
A well-known acne drug may increase cholesterol and other fat levels more than previously thought, U.S. researchers said on Monday.
NEW YORK (Reuters Health) - People with severe acne who achieve clearer skin with a combination of an oral antibiotic and anti-acne gels applied to the skin are often able to maintain their clearer complexion by using gels alone, according to two studies in the Archives of Dermatology.
NEW YORK (Reuters Health) - Low doses of isotretinoin (brand name, Roaccutane or Accutane) are effective for treating moderate acne, according to a study in the Journal of the American Academy of Dermatology.
- To swell, as grain or wood with water.